Neil Chanchlani

23PUBLICATIONS
80CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Nanotoxicology, health and safetyAllergyInfant and child healthInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Oct 13, 2025
Understanding Anti-TNF Treatment Failure: Pre-Existing Antidrug Antibodies Are Common but Do Not Neutralize Drug Activity In Vitro or Influence Clinical Response to Infliximab or Adalimumab in Patients with Crohn Disease.

Rachel Nice, Simeng Lin, Neil Chanchlani

|Jun 23, 2025
Clinical Utility and Cost-Effectiveness of Pretreatment NUDT15 Pharmacogenetic Testing to Prevent Thiopurine-Induced Myelosuppression: A Genotype-First Reverse Phenotyping Cohort Study Within the UK NIHR Inflammatory Bowel Disease Bioresource.

Christopher Roberts, Jaime Peters, Aleksejs Sazonvos

|Nov 22, 2024
Therapeutic drug monitoring for immune mediated inflammatory diseases.

Neil Chanchlani, Zenas Z N Yiu, Lisa K Stamp

|Feb 19, 2024
Sustained Increase in Pediatric Inflammatory Bowel Disease Incidence Across the South West United Kingdom Over the Last 10 Years.

Zachary Green, James J Ashton, Astor Rodrigues

|Sep 30, 2023
Baseline Expression of Immune Gene Modules in Blood is Associated With Primary Response to Anti-TNF Therapy in Crohn's Disease Patients.

Benjamin Y H Bai, Mark Reppell, Nizar Smaoui

|Aug 08, 2023
Whole Blood DNA Methylation Changes Are Associated with Anti-TNF Drug Concentration in Patients with Crohn's Disease.

Simeng Lin, Eilis Hannon, Mark Reppell

Pageof 4

Frequent Collaborators

18 joint publications

Tariq Ahmad

16 joint publications

Simeng Lin

16 joint publications

James R Goodhand

16 joint publications

Nick Kennedy